Rajangam Kanya 4
4 · Nkarta, Inc. · Filed Aug 9, 2021
Insider Transaction Report
Form 4
Nkarta, Inc.NKTX
Rajangam Kanya
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-08-05$0.41/sh+10,000$4,100→ 10,000 total - Exercise/Conversion
Stock Option (right to buy)
2021-08-05−10,000→ 44,054 totalExercise: $0.41Exp: 2028-12-06→ Common Stock (10,000 underlying) - Sale
Common Stock
2021-08-05$37.28/sh−10,000$372,800→ 0 total
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.
- [F2]This transaction was executed in multiple trades at prices ranging from $37.02 to $37.63, inclusive. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on December 3, 2022.